Cardiovascular Systems, Inc.
CSII
CSII was delisted on the 27th of April, 2023.
161 hedge funds and large institutions have $491M invested in Cardiovascular Systems, Inc. in 2022 Q4 according to their latest regulatory filings, with 19 funds opening new positions, 62 increasing their positions, 53 reducing their positions, and 18 closing their positions.
17% more repeat investments, than reductions
Existing positions increased: 62 | Existing positions reduced: 53
6% more first-time investments, than exits
New positions opened: 19 | Existing positions closed: 18
5% less capital invested
Capital invested by funds: $515M → $491M (-$24.2M)
1% less funds holding
Funds holding: 163 → 161 (-2)
91% less call options, than puts
Call options by funds: $15K | Put options by funds: $168K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$5.71M |
| 2 |
BlackRock
New York
|
+$5.26M |
| 3 |
Norges Bank
Oslo,
Norway
|
+$3.07M |
| 4 |
PM
Prosight Management
Dallas,
Texas
|
+$2.03M |
| 5 |
State Street
Boston,
Massachusetts
|
+$1.38M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BCM
Brown Capital Management
Baltimore,
Maryland
|
-$18.6M |
| 2 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
-$3.5M |
| 3 |
Renaissance Technologies
New York
|
-$2.07M |
| 4 |
Goldman Sachs
New York
|
-$1.74M |
| 5 |
BNP Paribas Financial Markets
Paris,
France
|
-$1.37M |
CSII Hedge Fund Activity: Q4 2022 in Review
161 of the 6,237 institutional investors tracked by Wall St. Rank reported a position in Cardiovascular Systems, Inc. (CSII) for Q4 2022, worth a combined $491M — down 4.7% from $515M a quarter earlier.
Buyers outnumbered sellers: 19 funds opened new CSII positions and 18 closed out — a net gain of 1 holder — while 62 added to existing stakes and 53 trimmed.
The largest buyer was Citadel Advisors, adding an estimated $5.71M. The largest seller was Brown Capital Management, cutting an estimated $18.6M.
- 161 institutional investors held Cardiovascular Systems, Inc. (CSII) as of Q4 2022, down from 163 in Q3 2022.
- Funds reported $491M of Cardiovascular Systems, Inc. stock for Q4 2022, down 4.7% quarter-over-quarter.
- 19 funds opened new Cardiovascular Systems, Inc. positions in Q4 2022 and 18 closed out, a net change of +1 holder.
- The largest Cardiovascular Systems, Inc. buyer in Q4 2022 was Citadel Advisors, an estimated $5.71M added.
- The largest Cardiovascular Systems, Inc. seller in Q4 2022 was Brown Capital Management, an estimated $18.6M sold.
Based on aggregated 13F filings for Q4 2022.